Records containing: Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-20A Multi-Stage Randomized Phase II Study of Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2026-04-17A Phase I/II Study of Pembrolizumab (MK-3475) in Japanese Pediatric Participants With Specific Solid Tumors or Lymphomas, or in Japanese Adult Participants With Advanced Merkel Cell Carcinoma (KEYNOTE-G21)
-
CLINICAL_TRIALS study record update · 2026-04-16An Open-Label, Single-Arm, Phase 1/2 Study Evaluating the Safety and Efficacy of Ponatinib for the Treatment of Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors in Pediatric Participants
-
CLINICAL_TRIALS study record update · 2026-04-15Addition of Inotuzumab Ozogamicin Pre- and Post-Allogeneic Transplantation
-
CLINICAL_TRIALS study record update · 2026-04-15Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-14Collection of Blood From Therapeutic Trial Participants for Analysis of Genetic Differences in Drug Disposition and Pharmacokinetics of Probe Medications
-
CLINICAL_TRIALS study record update · 2026-04-14Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Patients With Stage I/II Nasal NK Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2026-04-13Phase Ib Study of Copanlisib in Combination With Nivolumab or With Nivolumab and Ipilimumab
-
CLINICAL_TRIALS study record update · 2026-04-13Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial
-
CLINICAL_TRIALS study record update · 2026-04-13Molecular Analysis for Therapy Choice (MATCH)
-
CLINICAL_TRIALS study record update · 2026-04-08IMPACT: Improving Access to Cancer Survivorship Via Telehealth
-
CLINICAL_TRIALS study record update · 2026-04-08Phase 2 Trial of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-Hodgkin Lymphomas
-
CLINICAL_TRIALS study record update · 2026-04-07Do Decreased Dietary Fat and Increased Fiber Reduce Recurrence of Clostridioides Difficile Infection in Oncology Patients?
-
CLINICAL_TRIALS study record update · 2026-04-07Observational Study of Commercial Chimeric Antigen Receptor T-cell (CAR T) Therapy in Older Patients With Hematologic Malignancies and With an Embedded Pilot Study of Longitudinal Geriatric and Neurocognitive Evaluation
-
CLINICAL_TRIALS study record update · 2026-04-07Epcoritamab With Lenalidomide and Tafasitamab in Patients With Relapsed/Refractory (R/R) Diffuse Large B Cell Lymphoma (DLBCL)
-
CLINICAL_TRIALS study record update · 2026-04-06A Multicentre, Open-label, Phase 3, Randomised Controlled Trial of Duvelisib Versus Investigator's Choice of Gemcitabine or Bendamustine in Patients With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype
-
CLINICAL_TRIALS study record update · 2026-04-03A Phase I Study to Investigate the Safety, Tolerability, and Preliminary Efficacy of Anti-CD30 Bispecific Antibody-Armed Anti-CD3-Activated Autologous T-Cells (CD30 biAb-AATC) in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-02A Phase Ib Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2026-04-02A Phase III, Open-Label, Multicenter Randomized Study Evaluating Glofitamab as a Single Agent Versus Investigator's Choice in Patients With Relapsed/Refractory Mantle Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2026-04-01A Phase II Study of Tazemetostat in Combination With CHOP for Previously Untreated T Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2026-03-31Feasibility Of Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy
-
CLINICAL_TRIALS study record update · 2026-03-31Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors
-
CLINICAL_TRIALS study record update · 2026-03-31TPG: a Phase 2 Trial of Polatuzumab Vedotin, Glofitamab, and Tafasitamab as Chemotherapy-sparing First-line Therapy for Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma
-
CLINICAL_TRIALS study record update · 2026-03-30Thriving Beyond Treatment: A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship.
-
CLINICAL_TRIALS study record update · 2026-03-30Phase I/II Study of Pembrolizumab and In-situ Injection of CMP-001 in Patients With Relapsed and Refractory Lymphomas